FORTIS NSE filing

Fortis Healthcare Appoints Mohd Shahazwan Bin Mohd Harris as Director

The RealCase readMedium impact Positive

Fortis Healthcare Limited has appointed Mr. Mohd Shahazwan Bin Mohd Harris as a Non-Independent & Non-Executive Director. The appointment was approved via postal ballot and e-voting, with the resolution passing on January 22, 2026. Over 99% of votes were in favour of the appointment.

Why it matters

The appointment of a new director is a significant corporate action that can influence the company's strategic direction and governance, thus having a medium impact.

The market read

The appointment of a new director was approved by a significant majority, indicating positive shareholder support for the company's board.

Fortis Healthcare Limited announced the successful appointment of Mr. Mohd Shahazwan Bin Mohd Harris as a Non-Independent & Non-Executive Director. The resolution for his appointment was approved with the requisite majority through e-voting, following a postal ballot notice issued on December 19, 2025.

The voting process concluded on January 22, 2026, with the results being finalized and reported on January 23, 2026. Mr. Harris is liable to retire by rotation. The company had previously sent the postal ballot notice electronically to its members on December 23, 2025, and published advertisements in Financial Express and Rozana Spokesman on December 24, 2025, to inform shareholders about the e-voting facility. The e-voting platform was provided by KFin Technologies Limited.

The final voting results indicated a strong approval for Mr. Harris's appointment. Out of a total of 654,756,573 votes cast, 650,781,446 votes were in favour, representing 99.3929%, while 3,975,127 votes were against, representing 0.6071%. The resolution is deemed to have been passed on January 22, 2026.

Filing to action

What to do with a filing like this

Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under board changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.

View original filing